EMV — EMvision Medical Devices Cashflow Statement
0.000.00%
Last trade - 00:00
- AU$173.06m
- AU$167.56m
- AU$7.09m
- 44
- 19
- 90
- 53
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Changes in Working Capital | 0 | 0.037 | 1.33 | 2.01 | 2.62 |
Other Operating Cash Flow | |||||
Cash from Operating Activities | -2.22 | -3.26 | -4.49 | -3.78 | 0.834 |
Capital Expenditures | — | — | -0.127 | -0.191 | -0.187 |
Purchase of Fixed Assets | |||||
Cash from Investing Activities | — | — | -0.127 | -0.191 | -0.187 |
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 5.58 | 4.28 | 8.9 | 1.08 | 2.52 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 3.37 | 1.03 | 4.28 | -2.89 | 3.17 |